non-small cell lung cancer

BioNTech initiates global trials of mRNA-based lung cancer vaccine
Clinical Trials Arena
Mon, 08/26/24 - 10:16 am
BioNTech
BNT116
non-small cell lung cancer
MRNA
clinical trials
Targeting AZ's Tagrisso, Johnson & Johnson's Rybrevant combo wins key FDA nod in first-line lung cancer
Fierce Pharma
Tue, 08/20/24 - 11:36 am
JNJ
AstraZeneca
FDA
non-small cell lung cancer
Rybrevant
Lazcluze
Tagrisso
FDA approves AstraZeneca's non-small cell lung cancer treatment
Reuters
Thu, 08/15/24 - 10:06 pm
AstraZeneca
Imfinzi
FDA
non-small cell lung cancer
FDA advisers, frustrated by AZ's Imfinzi design, call for revamp of perioperative lung cancer trials
Fierce Pharma
Thu, 07/25/24 - 09:59 pm
FDA
ODAC
clinical trials
non-small cell lung cancer
AstraZeneca
Imfinzi
FDA Flags Potential ‘Overtreatment’ for NSCLC With AstraZeneca’s Imfinzi Ahead of Adcomm
BioSpace
Wed, 07/24/24 - 11:32 am
AstraZeneca
Imfinzi
non-small cell lung cancer
FDA
Roche Axes Phase II/III NSCLC Study as TIGIT Drug Loses to Keytruda-Chemo Combo
BioSpace
Mon, 07/8/24 - 11:41 am
Roche
clinical trials
tiragolumab
non-small cell lung cancer
Despite J&J's Rybrevant full nod, FDA encourages Dizal to file rival lung cancer drug for accelerated approval
Fierce Pharma
Thu, 06/27/24 - 10:08 pm
JNJ
Rybrevant
Dizal Pharma
FDA
non-small cell lung cancer
AstraZeneca’s Imfinzi fails adjuvant trial in lung cancer
Pharmaphorum
Tue, 06/25/24 - 11:25 am
AstraZeneca
Imfinzi
clinical trials
non-small cell lung cancer
5 FDA Decisions to Watch in the Second Half of 2024
BioSpace
Mon, 06/24/24 - 11:29 am
FDA
Eli Lilly
donanemab
Alzheimer's disease
Adaptimmune
afami-cel
advanced synovial sarcoma
Lykos Therapeutics
MDMA
PTSD
Bristol Myers Squibb
KarXT
schizophrenia
Daiichi Sankyo
AstraZeneca
Dato-DXd
non-small cell lung cancer
ASCO: AstraZeneca's Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation
Fierce Pharma
Mon, 06/3/24 - 12:10 pm
ASCO 2024
AstraZeneca
Tagrisso
Imfinzi
lung cancer
non-small cell lung cancer
ASCO 24: Data shows survival benefit with J&J’s subcutaneous Rybrevant
Clinical Trials Arena
Mon, 06/3/24 - 12:03 pm
ASCO 2024
JNJ
Rybrevant
non-small cell lung cancer
ASCO: Bristol Myers' KRAS confirmatory data avoid Amgen's flaws but leave FDA prospect unclear
Fierce Pharma
Sun, 06/2/24 - 02:51 pm
ASCO 2024
Bristol Myers Squibb
Amgen
KRAS inhibitors
Krazati
non-small cell lung cancer
As Bristol Myers reveals trial failure, AstraZeneca's Imfinzi stays king in stage 3 lung cancer
Fierce Pharma
Mon, 05/13/24 - 11:20 am
Bristol Myers Squibb
Opdivo
Yervoy
clinical trials
non-small cell lung cancer
AstraZeneca
Imfinzi
Roche wins FDA OK for targeted drug in early lung cancer
BioPharma Dive
Fri, 04/19/24 - 11:40 am
Roche
Alecensa
ALK inhibitors
FDA
non-small cell lung cancer
AstraZeneca’s Tagrisso maintains momentum in NSCLC with FLAURA2 results
Clinical Trials Arena
Fri, 04/19/24 - 11:26 am
AstraZeneca
non-small cell lung cancer
Tagrisso
5 Successful Phase III Oncology Trials in Q1
BioSpace
Tue, 04/9/24 - 11:50 am
oncology
clinical trials
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Pfizer
DLBCL
Adcetris
Asieris
HSIL
APL-1702
cervical cancer
Novocure
non-small cell lung cancer
Roche
Genentech
Tecentriq
esophageal squamous cell carcinoma
FDA grants breakthrough status to Dizal’s sunvozertinib
Pharmaceutical Business Review
Mon, 04/8/24 - 11:54 am
Dizal Pharmaceutical
FDA
non-small cell lung cancer
sunvozertinib
BMS Pulls Ahead of Amgen, Aces Confirmatory Phase III NSCLC Trial for Krazati
BioSpace
Mon, 04/1/24 - 11:59 am
Bristol Myers Squibb
clinical trials
adagrasib
Krazati
non-small cell lung cancer
EU Approves Merck’s Keytruda, Chemo Combo for Lung Cancer
BioSpace
Thu, 03/28/24 - 04:56 pm
Merck
Europe
Keytruda
non-small cell lung cancer
Novocure's lung cancer device slows progression to brain in trial, shares rise
Reuters
Wed, 03/27/24 - 10:51 am
Novocure
clinical trials
Medtech
lung cancer
tumor treating fields
non-small cell lung cancer

Pages